UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038300
Receipt number R000043434
Scientific Title Evaluation of effects of consumption of lactic acid bacteria on skin conditions of females
Date of disclosure of the study information 2019/10/15
Last modified on 2020/06/30 15:03:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of effects of consumption of lactic acid bacteria on skin conditions of females

Acronym

Evaluation of effects of consumption of lactic acid bacteria on skin conditions of females

Scientific Title

Evaluation of effects of consumption of lactic acid bacteria on skin conditions of females

Scientific Title:Acronym

Evaluation of effects of consumption of lactic acid bacteria on skin conditions of females

Region

Japan


Condition

Condition

No

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effect of lactic acid bacteria on skin condition in healthy females.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Skin hydration in stratum corneum and transepidermal water loss

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

A beverage containing lactic acid bacteria (130 mL/day for 8 weeks)

Interventions/Control_2

A beverage not containing lactic acid bacteria (130 mL/day for 8 weeks)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Female

Key inclusion criteria

1. Japanese healthy females aged 20 to 59 years-old at acquisition of the consent.
2. Who have subjective symptoms of dry skin
3. Who can make self-judgment, voluntarily agreed to participate to this study, and provide written informed consent.

Key exclusion criteria

1. Who have any disease
2. Who take any medicines or foods which affect intestinal flora
3. Who take any medicines or foods which affect skin moisture
4. Who have allergic to apple, soy bean, dairy food
5. Who had surgery or treatment on skin within two months
6. Who expose to high-intensity ultraviolet rays.
7. Who are pregnant or breast-feeding or willing to be pregnant during this study.
8. Who have participated in other clinical study for skin during this study, or willing to be that.
9. A person of irregular habits.
10, Who are judged unsuitable for this study by principal investigator.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Shigenori
Middle name
Last name Suzuki

Organization

KAGOME CO., LTD.

Division name

Nature & Wellness Research Department

Zip code

329-2762

Address

17 Nishitomiyama, Nasushiobara city, Tochigi

TEL

0287-36-2935

Email

Shigenori_Suzuki@kagome.co.jp


Public contact

Name of contact person

1st name Naoko
Middle name
Last name Waki

Organization

KAGOME CO., LTD.

Division name

Nature & Wellness Research Department

Zip code

329-2762

Address

17 Nishitomiyama, Nasushiobara city, Tochigi

TEL

0287-36-2935

Homepage URL


Email

Naoko_Waki@kagome.co.jp


Sponsor or person

Institute

KAGOME CO., LTD.

Institute

Department

Personal name



Funding Source

Organization

KAGOME CO., LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Kirei Testing Labo Co., Ltd.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kagome Ethics Committee

Address

3-21-1, F tower, Hamacho, Nihonbashi, Tyuo-ku, Tokyo, Japan

Tel

03-5623-8501

Email

Takuji_Hayakawa@kagome.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

株式会社きれいテストラボ(東京都)/Kirei Testing Labo Co., Ltd. (Tokyo, Japan)


Other administrative information

Date of disclosure of the study information

2019 Year 10 Month 15 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

99

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2019 Year 08 Month 27 Day

Date of IRB

2019 Year 08 Month 27 Day

Anticipated trial start date

2019 Year 10 Month 16 Day

Last follow-up date

2019 Year 12 Month 19 Day

Date of closure to data entry

2020 Year 01 Month 31 Day

Date trial data considered complete


Date analysis concluded

2020 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2019 Year 10 Month 15 Day

Last modified on

2020 Year 06 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043434


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name